Volltextsuche nutzen
- versandkostenfrei ab € 30,–
- 6x in Wien und Salzburg
- 6 Mio. Bücher
- facultas
- Detailansicht
Association of hepatitis B and C viruses infections with lung cancer
Taschenbuch
77,00€
inkl. gesetzl. MwSt.
Herstellung bei AnforderungVersandkostenfreibestellen in Österreich
Deutschland: € 10,00
EU & Schweiz: € 20,00
EU & Schweiz: € 20,00
In den Warenkorb
Click & Collect
Artikel online bestellen und in der Filiale abholen.
Derzeit in keiner facultas Filiale lagernd. Jetzt online bestellen!Artikel online bestellen und in der Filiale abholen.
Artikel in den Warenkorb legen, zur Kassa gehen und Wunschfiliale auswählen. Lieferung abholen und bequem vor Ort bezahlen.
Auf die Merkliste
Veröffentlicht 2013, von Adel Ahmed Mohammed, Noha Elsayed Ibrahim bei LAP Lambert Academic Publishing
ISBN: 978-3-659-38089-1
264 Seiten
220 mm x 150 mm
Although the prevalence of HCV- antibodies in patients with lung cancer was shown to be significantly higher than healthy individuals in Egypt, the development of lung cancer is probably a multifactorial process and in patients with lung cancer, anti- HCV positivity alone may not be sufficient evidence for a causal relation between HCV infection and lung cancer. It is worth while to investigate ...
Beschreibung
Although the prevalence of HCV- antibodies in patients with lung cancer was shown to be significantly higher than healthy individuals in Egypt, the development of lung cancer is probably a multifactorial process and in patients with lung cancer, anti- HCV positivity alone may not be sufficient evidence for a causal relation between HCV infection and lung cancer. It is worth while to investigate the impact of the relatively high incidence of HCV in Egypt whether in causing hepatic or extreahepatic malignancy. More work is relatively needed to investigate the possibility of association of lung cancer and other extrahepatic malignancy with HCV and HBV infection.
Although the prevalence of HCV- antibodies in patients with lung cancer was shown to be significantly higher than healthy individuals in Egypt, the development of lung cancer is probably a multifactorial process and in patients with lung cancer, anti- HCV positivity alone may not be sufficient evidence for a causal relation between HCV infection and lung cancer. It is worth while to investigate the impact of the relatively high incidence of HCV in Egypt whether in causing hepatic or extreahepatic malignancy. More work is relatively needed to investigate the possibility of association of lung cancer and other extrahepatic malignancy with HCV and HBV infection.